IgM RF |
|
|
|
Inflammation 3 years earlier |
0.06 (−0.01 to 0.12) |
0.07 (0.04 to 0.10) |
0.18 (0.07 to 0.29) |
Inflammation 2 years earlier |
0.07 (0.01 to 0.13) |
0.05 (0.02 to 0.08) |
0.16 (0.06 to 0.25) |
Inflammation 1 year earlier |
0.12 (0.06 to 0.18) |
0.05 (0.01 to 0.08) |
0.19 (0.10 to 0.29) |
Inflammation at same point in time |
0.09 (0.04 to 0.13) |
0.07 (0.04 to 0.09) |
0.20 (0.13 to 0.27) |
Inflammation 1 year later |
0.06 (0.00 to 0.12) |
0.04 (0.02 to 0.07) |
0.15 (0.06 to 0.24) |
Inflammation 2 years later |
0.11 (0.05 to 0.16) |
0.02 (−0.01 to 0.04) |
0.14 (0.05 to 0.23) |
Inflammation 3 years later |
0.05 (−0.01 to 0.12) |
0.02 (−0.01 to 0.05) |
0.09 (−0.01 to 0.20) |
|
|
|
|
Anti‐CCP |
|
|
|
Inflammation 3 years earlier |
0.05 (0.00 to 0.10) |
−0.02 (−0.05 to 0.01) |
0.00 (−0.09 to 0.09) |
Inflammation 2 years earlier |
0.03 (−0.03 to 0.08) |
−0.01 (−0.03 to 0.02) |
0.01 (−0.07 to 0.09) |
Inflammation 1 year earlier |
0.08 (0.03 to 0.13) |
0.00 (−0.03 to 0.03) |
0.08 (−0.01 to 0.16) |
Inflammation at same point in time |
0.05 (0.02 to 0.09) |
0.05 (0.02 to 0.07) |
0.13 (0.07 to 0.19) |
Inflammation 1 year later |
0.00 (−0.05 to 0.05) |
0.01 (−0.02 to 0.03) |
0.01 (−0.07 to 0.04) |
Inflammation 2 years later |
0.08 (0.03 to 0.14) |
0.02 (0.00 to 0.05) |
0.13 (0.04 to 0.21) |
Inflammation 3 years later |
0.06 (−0.01 to 0.13) |
0.01 (−0.02 to 0.05) |
0.09 (−0.01 to 0.19) |